Efficacy and safety of empagliflozin and metformin with sitagliptin and metformin during Ramadan: An observational study

被引：0

作者：

Ahmed, I. ^{[1
]}

Raja, U. ^{[2
]}

Wahab, U. ^{[3
]}

Aamir, A. H. ^{[4
]}

Ghaffar, T. ^{[4
]}

Kumar, S. ^{[5
]}

Raza, A. ^{[6
]}

Masood, F. ^{[7
]}

Asghar, A. ^{[8
]}

Tejhmal, R. ^{[9
]}

Randhawa, F. A. ^{[10
]}

Sherin, A. ^{[11
]}

机构：

[1] Lady Reading Hosp, Endocrinol, Peshawar, Pakistan

[2] Shifa Int Hosp, Diabet & Endocrinol, Islamabad, Pakistan

[3] Umar Diabet Fdn, Diabet, Islamabad, Pakistan

[4] Hayatabad Med Complex, Endocrinol, Peshawar, Pakistan

[5] Bolan Med Coll, Endocrinol, Quetta, Pakistan

[6] Shauqat Khanum Hosp, Endocrinol, Lahore, Pakistan

[7] AlKhaliq Hosp, Diabet, Multan, Pakistan

[8] Liaqat Natl Hosp, Endocrinol, Karachi, Pakistan

[9] Shifa Int Hosp, Endocrinol, Islamabad, Pakistan

[10] Mayo Hosp, Endocrinol, Lahore, Pakistan

[11] KMU Inst Med Sci, Med, Kohat, Pakistan

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷

关键词：

D O I：

10.1016/j.diabres.2022.109586

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IDF21-0642

引用

页数：2

共 50 条

[41] Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2 diabetes
Scott, Russell
Loeys, Tom
Davies, Michael J.
Engel, Samuel S.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S32 - S32
[42] A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus
Poornima, R.
Brigida, S.
Elizabeth, Arul Amutha
Soujania, G.
Lella, Tanuja
JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 7 - 12
[43] Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
Park, Young-Hwan
Sohn, Minji
Lee, So Yeon
Lim, Soo
DIABETES & METABOLISM JOURNAL, 2024, 48 (02) : 253 - 264
[44] Observational study of the efficacy of prolonged-release metformin in people with prediabetes
Hostalek, Ulrike
Zilahi, Zsolt
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (03) : 397 - 401
[45] Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
Seck, T.
Nauck, M.
Sheng, D.
Sunga, S.
Davies, M. J.
Stein, P. P.
Kaufman, K. D.
Amatruda, J. M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 562 - 576
[46] Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial
Mondal Aashish
Naskar Arindam
Sheelu Shafiq Siddiqi
Deepak Bhosle
V. J. Mallikarjuna
Dange Amol
Sorate Sanket
Gavali Omkar
Patel Parth
Hasnani Dhruvi
Prasad Durga
Dalwadi Pradeep
Kumar Suresh
Pathak Vaishali
Chaudhari Mayura
Basu Indraneel
Shembalkar Jayashri
Fariooqui Arif
S. K. Raghavendra
Varade Deepak
Thakkar Ravindra
Bhanushali Shaishav
Gaikwad Vijay
Kamran Khan
V. V. Mahajani
A. D. Sharma
Mayur Mayabhate
R. R. Pawar
A. S. Aiwale
Shahavi Vinayaka
Clinical Diabetes and Endocrinology, 10 (1):
[47] Efficacy and Safety of Add-On Vildagliptin to Metformin in Comparison to Uptitrating Metformin Therapy
Kim, Nan Hee
Sung, Yeon-Ah
Ahn, Chul Woo
Park, Seok Won
Lim, Soo
Kim, Chul Hee
Kim, Dong Sun
Shin, Young Goo
Ahn, Kyu Jeung
Kim, Jae Hyeon
Baik, Sei Hyun
DIABETES, 2012, 61 : A297 - A297
[48] Empagliflozin, metformin and insulin degludec, during pregnancy: a case report
G. Formoso
F. Ginestra
G. Di Dalmazi
A. Consoli
Acta Diabetologica, 2018, 55 : 759 - 761
[49] Efficacy and Tolerability of Sitagliptin in Type 2 Diabetic Patients Inadequately Controlled with Metformin. A Prospective Observational Study in Austrian Primary Care
Ludvik, Bernhard
Daniela, Lutz
WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (7-8) : 235 - 240
[50] Empagliflozin/metformin/vildagliptinLack of efficacy and euglycemic diabetic ketoacidosis: case report
Reactions Weekly, 2021, 1871 (1) : 158 - 158

← 1 2 3 4 5 →